139 related articles for article (PubMed ID: 32114667)
1. Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series.
Anghileri E; Schettino C; Pollo B; Farinotti M; Silvani A; Paterra R; Patanè M; DiMeco F; Bruzzone MG; Eoli M; Cuccarini V
Neurol Sci; 2020 Aug; 41(8):2111-2120. PubMed ID: 32114667
[TBL] [Abstract][Full Text] [Related]
2. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
[TBL] [Abstract][Full Text] [Related]
3. Revisiting prognostic factors of gliomatosis cerebri in adult-type diffuse gliomas.
Shin I; Sim Y; Choi SH; Park YW; Lee N; Ahn SS; Chang JH; Kim SH; Lee SK
J Neurooncol; 2024 Jun; 168(2):239-247. PubMed ID: 38700610
[TBL] [Abstract][Full Text] [Related]
4. Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study.
Ly KI; Oakley DH; Pine AB; Frosch MP; Chiou SH; Betensky RA; Pomerantz SR; Hochberg FH; Batchelor TT; Cahill DP; Dietrich J
Oncologist; 2019 Mar; 24(3):402-413. PubMed ID: 30097523
[TBL] [Abstract][Full Text] [Related]
5. Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas.
Broniscer A; Chamdine O; Hwang S; Lin T; Pounds S; Onar-Thomas A; Shurtleff S; Allen S; Gajjar A; Northcott P; Orr BA
Acta Neuropathol; 2016 Feb; 131(2):299-307. PubMed ID: 26744350
[TBL] [Abstract][Full Text] [Related]
6. Gliomatosis cerebri: clinical characteristics, management, and outcomes.
Chen S; Tanaka S; Giannini C; Morris J; Yan ES; Buckner J; Lachance DH; Parney IF
J Neurooncol; 2013 Apr; 112(2):267-75. PubMed ID: 23341100
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors and Survival of Gliomatosis Cerebri: A Systematic Review and Meta-Analysis.
Georgakis MK; Tsivgoulis G; Spinos D; Liaskas A; Herrlinger U; Petridou ET
World Neurosurg; 2018 Dec; 120():e818-e854. PubMed ID: 30172970
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of molecular subgrouping of gliomatosis cerebri per 2016 WHO classification: a clinicopathological study of 89 cases.
Kwon MJ; Kang SY; Cho H; Lee JI; Kim ST; Suh YL
Brain Pathol; 2020 Mar; 30(2):235-245. PubMed ID: 31435963
[TBL] [Abstract][Full Text] [Related]
9. Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III Gliomas.
Divé I; Steidl E; Wagner M; Filipski K; Burger MC; Franz K; Harter PN; Bähr O; Fokas E; Herrlinger U; Steinbach JP
Oncology; 2021; 99(4):215-224. PubMed ID: 33472203
[TBL] [Abstract][Full Text] [Related]
10. Gliomatosis cerebri: A consensus summary report from the First International Gliomatosis cerebri Group Meeting, March 26-27, 2015, Paris, France.
Greenfield JP; Castañeda Heredia A; George E; Kieran MW; Morales La Madrid A
Pediatr Blood Cancer; 2016 Dec; 63(12):2072-2077. PubMed ID: 27466787
[TBL] [Abstract][Full Text] [Related]
11. Patterns of presentation and failure in patients with gliomatosis cerebri treated with partial-brain radiation therapy.
Kandula S; Saindane AM; Prabhu RS; Hanasoge S; Patel KR; Shu HK; Curran WJ; Crocker IR
Cancer; 2014 Sep; 120(17):2713-20. PubMed ID: 24845411
[TBL] [Abstract][Full Text] [Related]
12. Gliomatosis cerebri having a poor performance status without recurrence after radiotherapy: a single institutional experience.
Jung TY; Yoon MS; Kim YH; Jung S; Kim IY; Jang WY; Moon KS; Lee KH; Kim SK
Clin Neurol Neurosurg; 2015 Mar; 130():1-5. PubMed ID: 25569296
[TBL] [Abstract][Full Text] [Related]
13. [Gliomatosis cerebri].
Sanson M; Napolitano M; Cartalat-Carel S; Taillibert S
Rev Neurol (Paris); 2005 Feb; 161(2):173-81. PubMed ID: 15798516
[TBL] [Abstract][Full Text] [Related]
14. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
Malzkorn B; Reifenberger G
Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
[TBL] [Abstract][Full Text] [Related]
15. Gliomatosis cerebri: growing evidence for diffuse gliomas with wide invasion.
Romeike B; Mawrin C
Expert Rev Neurother; 2008 Apr; 8(4):587-97. PubMed ID: 18416661
[TBL] [Abstract][Full Text] [Related]
16. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
Seiz M; Tuettenberg J; Meyer J; Essig M; Schmieder K; Mawrin C; von Deimling A; Hartmann C
Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489
[TBL] [Abstract][Full Text] [Related]
17. Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data.
Georgakis MK; Tsivgoulis G; Spinos D; Dimitriou NG; Kyritsis AP; Herrlinger U; Petridou ET
J Neurooncol; 2018 Nov; 140(2):467-475. PubMed ID: 30117023
[TBL] [Abstract][Full Text] [Related]
18. [Gliomatosis Cerebri as a Clinical Entity].
Sugiyama K
Brain Nerve; 2017 Jan; 69(1):35-43. PubMed ID: 28126976
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients.
Autran D; Barrie M; Matta M; Monserrat C; Campello C; Petrirena G; Boucard C; Padovani L; Loundou A; Appay R; Graillon T; Dufour H; Figarella-Branger D; Chinot O; Tabouret E
Anticancer Res; 2019 Feb; 39(2):1035-1041. PubMed ID: 30711992
[TBL] [Abstract][Full Text] [Related]
20. Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.
Carroll KT; Hirshman B; Ali MA; Alattar AA; Brandel MG; Lochte B; Lanman T; Carter B; Chen CC
World Neurosurg; 2017 Jul; 103():186-193. PubMed ID: 28366748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
